Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The trial will test the hypothesis that an intravitreal injection of triamcinolone is safe
and efficacious for patients with clinically significant diabetic macular oedema that is
recalcitrant to conventional laser therapy